MEDIA ADVISORY: Public-Private ATOM Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to One
Scientists from Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and the University of California, San Francisco will hold a briefing to discuss Accelerating Therapeutics for Opportunities in Medicine